Literature DB >> 30852575

Body Mass Index at Diagnosis as a Prognostic Factor for Early-Stage Invasive Breast Cancer after Surgical Resection.

Xue Wang1, Tian-Li Hui1, Mei-Qi Wang1, Huan Liu1, Ruo-Yang Li1, Zhen-Chuan Song2.   

Abstract

BACKGROUND: The aim of this study was to investigate the association between body mass index (BMI) and prognosis of Chinese women with breast cancer. PATIENTS AND METHODS: 3,380 primary breast cancer patients who underwent surgery from 2010 to 2012 were selected and classified as low BMI group (BMI < 25.0) and high BMI group (BMI ≥ 25.0). The follow-up data for disease-free survival (DFS) and overall survival (OS) were obtained from 3,178 patients (median follow-up of 58 months). Cox regression analysis was used to evaluate the effect of BMI on DFS and OS.
RESULTS: The high BMI group showed more aggressive pathological features. BMI was negatively associated with OS (hazard ratio (HR) 1.33, 95% confidence interval (CI) 1.06-1.66; p = 0.012) but not DFS (HR 1.15, 95% CI 0.94-1.40; p = 0.17). Furthermore, when stratified by age, BMI was significantly and negatively associated with OS (HR 1.43, 95% CI 1.05-1.95; p = 0.025) in patients above 50 years of age, but this effect was not detected in younger patients.
CONCLUSION: BMI was an independent prognostic factor of OS in Chinese women with breast cancer, and age might be a mitigating factor. Among patients above 50 years of age, those with a high BMI were at greater risk of poor prognosis compared to individuals with a low BMI.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Body mass index; Breast cancer; Overweight; Prognosis

Mesh:

Year:  2019        PMID: 30852575     DOI: 10.1159/000496548

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


  4 in total

Review 1.  Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis.

Authors:  Yuanjie Pang; Yuxia Wei; Christiana Kartsonaki
Journal:  Breast Cancer       Date:  2022-05-17       Impact factor: 3.307

2.  Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus.

Authors:  Tianli Hui; Chao Shang; Liu Yang; Meiqi Wang; Ruoyang Li; Zhenchuan Song
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

Review 3.  Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence.

Authors:  Nahlah Makki Almansour
Journal:  Front Mol Biosci       Date:  2022-01-25

Review 4.  Current Landscape: The Mechanism and Therapeutic Impact of Obesity for Breast Cancer.

Authors:  Chongru Zhao; Weijie Hu; Yi Xu; Dawei Wang; Yichen Wang; Wenchang Lv; Mingchen Xiong; Yi Yi; Haiping Wang; Qi Zhang; Yiping Wu
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.